UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Alon Unger, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.D.2007 Medicine
    University of California, San Francisco, CA2020Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Alon Unger, MD is an Assistant Clinical Professor in the Division of Hospital Medicine in the Department of Medicine. He went to medical school at UCSF and completed dual residencies in Internal Medicine and Pediatrics at UCLA. He also completed a Masters in Epidemiology at the London School of Hygiene and Tropical Medicine, and he has worked in various settings including South Africa, Uganda, Thailand and Brazil. He recently completed one year of service to Doctors without Borders in Myanmar as the HIV advisor to a large treatment program.

    Currently, Alon attends on the inpatient medicine service supervising residents and medical students, and also works part-time at the San Francisco General Hospital. He has a long-standing interest in global health, and he has been involved in research and service projects in both communicable and non-communicable diseases in slum settings.

    Collapse ORNG Applications 
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Unger A, Felzemburgh RD, Snyder RE, Ribeiro GS, Mohr S, Costa VB, Melendez AX, Reis RB, Santana FS, Riley LW, Reis MG, Ko AI. Hypertension in a Brazilian urban slum population. J Urban Health. 2015 Jun; 92(3):446-59. PMID: 25920334.
      View in: PubMed
    2. Unger A.. Arch Dis Child. Children's health in slum setting. 2013; 10(98):799-805.
    3. Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL. Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis. 2011 Jan 03; 11:1. PMID: 21199579.
      View in: PubMed
    4. Unger A, O'Neal S, Machado PR, Guimaraes LH, Morgan DJ, Schriefer A, Bacellar O, Glesby MJ, Carvalho EM.Am J Trop Med Hyg. Association of treatment of American cutaneous leishmaniasis prior to ulcer developmen with high rate of failure in northeastern Brazil. 2009; 4(80):574-9.
    5. Unger A, Riley LW. Slum health: from understanding to action. PLoS Med. 2007 Oct; 4(10):1561-6. PMID: 17958462.
      View in: PubMed
    6. Riley LW, Ko AI, Unger A, Reis MG. Slum health: diseases of neglected populations. BMC Int Health Hum Rights. 2007 Mar 07; 7:2. PMID: 17343758.
      View in: PubMed
    7. Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med. 2007 Jun 01; 175(11):1199-206. PMID: 17290042.
      View in: PubMed
    8. Riley LW, Ko AI, Unger A, Reis MG.BMC Int Health Hum Rights. Slum health: diseases of neglected populations. 2007; 7(7):1-6.
    9. Unger A, Riley LW.PLoS Med. Slum health: from understanding to action. 2007; 10(4):1561-6.